These innovative medications, like copyright and Semaglutide, represent a significant class of drugs called GLP-1 receptor mimics. They work by increasing the body's intrinsic ability to produce GLP-1, a hormone that helps manage sugar levels and food intake. Originally, developed for addressing type 2 high blood sugar, these medications have also